Scarica l'app Stockscreener
3.315
1.07%
0.035
Dopo l'orario di chiusura:
3.30
-0.015
-0.45%
Incannex Healthcare Inc Borsa (IXHL) Ultime notizie
Incannex Wins US Patent Lift For Sleep Apnoea Pipeline (ASX:IHL) - Kalkine Media
Why Did IXHL Stock Tank Over 32% Today? - Stocktwits
IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits
Polar Asset Management (IXHL) reports 7.0% beneficial stake via 900,000 warrants - Stock Titan
$Incannex Healthcare (IXHL.US)$ - Moomoo
Incannex (ASX:IHL): What Is Changing in the Liquidity Test? - Kalkine Media
Why Does Incannex Healthcare (ASX:IHL) Shape Discipline? - Kalkine Media
Incannex Healthcare (ASX:IHL) Clinical Development Pipeline: Market Outlook - Kalkine Media
Incannex Healthcare Inc. (IXHL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incannex Healthcare Inc. (IXHL) options chain - Yahoo Finance Singapore
Why Are Incannex Healthcare (ASX:IHL), Cann Group (ASX:CAN), ECS Botanics (ASX:ECS) and Little Green Pharma (ASX:LGP) Back in the Market Spotlight? - Kalkine Media
Why Are BrainChip (ASX:BRN), Incannex Healthcare (ASX:IHL), Lake Resources (ASX:LKE) and Cann Group (ASX:CAN) Back in the Market Spotlight? - Kalkine Media
Incannex receives final A$5.1m R&D tax incentive refund By Investing.com - Investing.com UK
Incannex Healthcare Inc. (IXHL) stock price, news, quote and history - Yahoo Finance Singapore
Incannex receives final A$5.1m R&D tax incentive refund - Investing.com
Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - The Manila Times
Form 8K Incannex Healthcare Inc. For: 11 August By Investing.com - Investing.com Nigeria
Press Release: Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - Moomoo
Incannex receives A$5.1M final R&D refund, totaling A$11.2M non-dilutive funding - TradingView
Can Incannex (ASX:IHL) Reshape The Cannabis Conversation? - Kalkine Media
Incannex Healthcare Inc (IXHL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Incannex Healthcare Inc. (IXHL) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Incannex Healthcare Inc (IXHL) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Incannex Healthcare Inc. Revenue Breakdown – NASDAQ:IXHL - TradingView
IXHL|Incannex Healthcare Inc|Price:2.985|Chg%:+0.035 - TradingKey
Incannex Healthcare Inc (IXHL) Institutional Confidence - TradingKey
Incannex Healthcare Inc (IXHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Incannex Healthcare Inc (IXHL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incannex Healthcare Inc (IXHL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Incannex Healthcare Inc. Commences Participant Screening In Dreamzz Phase 2 Study Of IHL-42X For Obstructive Sleep Apnea - marketscreener.com
Incannex starts screening for Phase 2 study of IHL-42X to treat obstructive sleep apnea with FDA Fast Track status - Pluang
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea - The Manila Times
Incannex Commences Screening in Phase 2 DReAMzz Study of IHL-42X for OSA - TradingView
What Has Incannex (ASX:IHL) in Health Debate? - Kalkine Media
IXHL Q2 2026 Earnings: Significant EPS Miss Amid Operational ExpendituresFree Cash Flow Trends - dars.gov.et
Incannex Healthcare (IXHL) Edges Higher: Technical Levels in Focus After Modest GainPCR Spike - dars.gov.et
Incannex Secures US Patent for Sleep Apnea Drug Candidate IHL-42X - Sleep Review
Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X - Yahoo Finance
Incannex Healthcare Q2 2026 Earnings: Large EPS Miss but Stock Gains as Investors Focus on Pipeline ProgressBalance Sheet Strength - dars.gov.et
IXHL Q2 2026 Earnings: Significant EPS Miss as Pre-Revenue Biotech Ramps Up R&D SpendingCash Flow Report - dars.gov.et
Incannex Healthcare(IXHL) Stock Options Chain | Quotes & News - Moomoo
Incannex Healthcare (ASX:IHL): Why Is This Cannabis Innovator Back in Focus? - Kalkine Media
Price to earnings forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Price to book forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
IXHL Q2 2026 Earnings: Significant EPS Miss Amid No Revenue, Yet Stock SurgesEarnings Yield Spread - dars.gov.et
Enterprise value to EBIT forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Price to sales forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
1.61%
1.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):